Please login to the form below

Not currently logged in

Oxford Pharmascience adds to board

John Goddard is former head of group strategic planning and business at AstraZeneca
John Goddard Oxford Pharmascience

Oxford Pharmascience has bulked up its board with the appointment of industry veteran John Goddard as independent non-executive director.

Goddard has years of experience in pharma including a spell as head of group strategic planning and business development at AstraZeneca until his retirement in 2010.

He joined AZ after his former company Zeneca merged with Astra in 1999.

Oxford Pharmascience's chair Dave Norwood commented that Goddard's experience in the industry would be valuable as the company initiates the commercialisation of its drug pipeline.

10th March 2014


Featured jobs

Subscribe to our email news alerts


Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

figure 1
The valuable brand
Creating value beyond the pill is both possible and increasingly necessary...
The rise of real-world evidence
Demonstrating efficacy and value requires more than clinical trial data...
Digital health
The untapped potential to transform healthcare...